Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva De Smedt

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Trends in Genetics : TIG|September 19, 2017
Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular PlasticityNicolas Skrypek, Steven Goossens, Eva De Smedt, et al.
Frontiers in Oncology|January 9, 2019
The Epigenome in Multiple Myeloma: Impact on Tumor Cell Plasticity and Drug ResponseEva De Smedt, Hui Lui, Ken Maes, et al.
Epigenetics & Chromatin|November 18, 2018
ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transitionNicolas Skrypek, Kenneth Bruneel, Cindy Vandewalle, et al.
Oncotarget|May 17, 2014
The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myelomaKen Maes, Eva De Smedt, Miguel Lemaire, et al.
Blood Advances|May 3, 2021
G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor-mediated cell deathEva De Smedt, Julie Devin, Catharina Muylaert, et al.
Oncotarget|February 12, 2015
In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myelomaKen Maes, Eva De Smedt, Alboukadel Kassambara, et al.
Scientific Reports|June 4, 2017
Confounding factors of ultrafiltration and protein analysis in extracellular vesicle researchGlenn Vergauwen, Bert Dhondt, Jan Van Deun, et al.
Clinical Epigenetics|September 17, 2021
Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myelomaLaurie Herviou, Sara Ovejero, Fanny Izard, et al.
Cancer Letters|November 13, 2018
Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathwayKim De Veirman, Eline Menu, Ken Maes, et al.
British Journal of Cancer|May 16, 2019
The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphomaAnke Maes, Ken Maes, Hendrik De Raeve, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Trends in Genetics : TIG|September 19, 2017
Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular PlasticityNicolas Skrypek, Steven Goossens, Eva De Smedt, et al.
Frontiers in Oncology|January 9, 2019
The Epigenome in Multiple Myeloma: Impact on Tumor Cell Plasticity and Drug ResponseEva De Smedt, Hui Lui, Ken Maes, et al.
Epigenetics & Chromatin|November 18, 2018
ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transitionNicolas Skrypek, Kenneth Bruneel, Cindy Vandewalle, et al.
Oncotarget|May 17, 2014
The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myelomaKen Maes, Eva De Smedt, Miguel Lemaire, et al.
Blood Advances|May 3, 2021
G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor-mediated cell deathEva De Smedt, Julie Devin, Catharina Muylaert, et al.
Oncotarget|February 12, 2015
In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myelomaKen Maes, Eva De Smedt, Alboukadel Kassambara, et al.
Scientific Reports|June 4, 2017
Confounding factors of ultrafiltration and protein analysis in extracellular vesicle researchGlenn Vergauwen, Bert Dhondt, Jan Van Deun, et al.
Clinical Epigenetics|September 17, 2021
Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myelomaLaurie Herviou, Sara Ovejero, Fanny Izard, et al.
Cancer Letters|November 13, 2018
Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathwayKim De Veirman, Eline Menu, Ken Maes, et al.
British Journal of Cancer|May 16, 2019
The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphomaAnke Maes, Ken Maes, Hendrik De Raeve, et al.
Pageof 2